Clinical Trial Update: Study Evaluating the Cost of the Treatments of the Refractory Psoriatic Arthritis to the Conventional Therapy

View source ↗

Summary

Pfizer-sponsored study evaluating the costs of treatments for refractory psoriatic arthritis compared with conventional therapy; the trial status is completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriatic Arthritis

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Psoriatic, Psoriasis | Status: COMPLETED | Results posted: 2012-07-30